FIELD: pharmacology.
SUBSTANCE: following are proposed: method for treating a subject suffering from ischemic damage or an acute ischemic event, comprising administering cysteamine, cystamine or a salt thereof, simultaneously with or immediately after the ischemic event, in an amount effective to reduce the ischemic damage, wherein the subject does not suffer from hypercholesterolemia or diabetes of II type, where the administration of cysteamine, cystamine or a salt thereof leads to an increase in adiponectin level with low molecular weight (LMW) (versions) in subjects; a method for increasing (versions) adiponectin levels with LMW in the mentioned patient group comprising contacting the subject with an effective amount of cysteamine, cystamine or a salt thereof (versions); the use of cysteamine, cystamine or a salt thereof in the manufacture of a medicament in the above mentioned treatment of a subject suffering from the acute ischemic event and not suffering from hypercholesterolemia or diabetes of II type.
EFFECT: levels of all adiponectin multimers are increased, within 1 hour after cysteamine exposure in the blood serum, LMW of adiponectin was rapidly and significantly increased, cysteamine administration 2 hours before the ischemic stroke significantly reduced the infarction area and the number of ischemic damages.
28 cl, 18 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) WITH USING CYSTEAMINE PRODUCTS | 2008 |
|
RU2498795C2 |
Oxy133 OXYSTEROL ANALOGUE INDUCTS OSTEOGENESIS AND SIGNAL WAY HEDGEHOG AND INHIBITED LIPOGENESIS | 2013 |
|
RU2632191C2 |
MATERIALS AND METHODS FOR METABOLISM MODULATION | 2005 |
|
RU2387445C2 |
METHOD OF PROPHYLAXIS OF NEPHROTOXICITY INDUCED BY CYCLOSPORINE OR TACROLIMUS | 1998 |
|
RU2191020C2 |
THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2019 |
|
RU2813780C2 |
CYSTEAMINE DIOXYGENASE-RESISTANT ANALOGUES OF CYSTEAMINE AND THEIR USE | 2016 |
|
RU2766579C2 |
METHOD OF REDUCING DEMAGE TO NERVOUS CELLS | 2007 |
|
RU2464977C2 |
SYSTEM DELIVERY AND REGULATED EXPRESSION OF PARACRINE GENES FOR TREATMENT OF CARDIOVASCULAR AND OTHER DISEASES | 2013 |
|
RU2642605C2 |
ANALOGUES OF CYSTAMINE, USED FOR PARKINSON'S DISEASE TREATMENT | 2012 |
|
RU2630583C2 |
COMPOSITIONS AND METHODS FOR TREATING DIABETES | 2004 |
|
RU2367423C2 |
Authors
Dates
2017-12-15—Published
2012-11-21—Filed